Status:
COMPLETED
Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies
Lead Sponsor:
asmaa salama ibrahim
Conditions:
Colorectal Carcinoma
Cancer
Eligibility:
All Genders
Brief Summary
This original research investigates the critical issue of gastrointestinal (GI) second primary malignancies (SPMs) in patients with signet ring cell carcinoma (SRCC), a rare and aggressive subtype of ...
Eligibility Criteria
Inclusion
- Patients diagnosed with primary colorectal SRCC between 2000 and 2021
- Latency exclusion period of two months
Exclusion
- patients with unknown age data
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
8171 Patients enrolled
Trial Details
Trial ID
NCT06978595
Start Date
January 1 2000
End Date
December 30 2021
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suez Canal University
Ismailia, Egypt, 41512